Interestingly, in hyper-mutated tumors, we observed concomitant somatic or germline mutations in the MMR and POL genes, with a median of three MMR/POL mutations per tumor, which was significantly higher than that of low-mutation tumors (a median of one MMR/POL mutation per tumor). The gene discussed is MRC1; the disease is neoplasm.